Mission
TO MAXIMIZE THE POTENTIAL OF ADVANCED IMMUNOLOGICAL DATA TO TRANSFORM HEALTH OUTCOMES FOR EVERYONE, EVERYWHERE.
Public Charity
HUMAN IMMUNOME PROJECT INC
HUMAN IMMUNOME PROJECT INC is a Public Charity headquartered in NEW YORK, NY. Financial data from the 2024 filing: $1.8M revenue, $2.3M expenses, $1.7M total assets. 4 publicly reported grants to this organization, totaling roughly $250K, appear in IRS filings.
EIN: 472364966
NEW YORK, NY
Latest filing: 2024
Total Revenue$1.8M
Total Expenses$2.3M
Total Assets$1.7M
Grant Records4
Funding Total$250K
Filing Years2019–2024
Sample Grants Received
GENERAL OPERATING SUPPORT
$25,000
In support of the Human Vaccines Project to reduce disparities and inequities in the research and development of vaccines for vulnerable populations.
$75,000
In support of the Human Vaccines Project to reduce disparities and inequities in the research and development of vaccines for vulnerable populations.
$75,000
FOR RECIPIENT'S EXEMPT PURPOSE
$75,000
Showing up to 5 of 4 total records — full history available with membership.
Officers & Directors
BOARD MEMBER
Douglas Richman
BOARD MEMBER/CEO
Hans Keirstead
BOARD CHAIR
Jane Metcalfe
BOARD MEMBER/FINANCE AUDIT & RISK
Jose-Maria Fernandez
BOARD MEMBER/FINANCE AUDIT & RISK
Kenneth Holroyd
BOARD MEMBER
Linda Avey
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1.8M | $2.3M | $1.7M |
| 2023 | $3.0M | $3.2M | $2.9M |
| 2022 | $3.4M | $2.8M | $3.1M |
| 2020 | $2.3M | $3.4M | $2.2M |
| 2019 | $4.4M | $5.7M | $3.5M |
Between 2019 and 2024, reported annual revenue declined from $4.4M to $1.8M (-59%), with total assets most recently reported at $1.7M.
Interactive year-over-year charts and full filing details available with membership.